Compugen Ltd. (CGEN) Announces Discovery of Genetic Biomarker for Predisposition to Type 2 Diabetes
11/9/2009 10:32:32 AM
More...
|
Compugen Ltd. (CGEN) Announces Preeclampsia Biomarker Collaboration
11/5/2009 9:56:08 AM
More...
|
Compugen Ltd. (CGEN) Presents DAC Blockers Platform and Initial Product Candidates at Fifth Peptide Engineering Meeting in Barcelona, Spain
10/26/2009 9:15:49 AM
More...
|
Compugen Ltd. (CGEN) to Review Third Quarter 2009 Results on Tuesday, October 27, 2009
10/20/2009 9:43:22 AM
More...
|
Compugen Ltd. (CGEN), Bayer Schering Pharma (JOBS) to Team up on Antibody Target Drug
10/13/2009 6:55:06 AM
More...
|
Compugen Ltd. (CGEN) Reports Second Quarter 2009 Results
7/28/2009 9:49:56 AM
More...
|
Compugen Ltd. (CGEN) Announces Positive Therapeutic Effects of Novel Peptide in Animal Model of Retinopathy
7/21/2009 9:50:16 AM
More...
|
Compugen Ltd. (CGEN) to Review Second Quarter 2009 Financial Results on Tuesday, July 28, 2009
7/20/2009 10:02:10 AM
More...
|
Compugen Ltd. (CGEN) Reports Sale of a Portion of Its Evogen Holdings
6/30/2009 9:11:00 AM
More...
|
Compugen Ltd. (CGEN) Announces Additional Grants from Israel Office of Chief Scientist for Validation Studies of Therapeutic Candidates
6/24/2009 9:21:24 AM
More...
|
|